i appreciate your cander. But I say "told you so" etc, to the people who trashed me just for my posts from the beginning. They should have it rubbed in their faces.
HHH, you don't seem like a bad guy, but just a piece of advice. No one appreciates a poster that says "I told you so". Bring it down a notch and you will fare much better. GLTY.
Sentiment: Strong Buy
Lost of thumbs down!!! I'LL TAKE THAT AS A COMPLIMENT!!! THANKS!! The thumbs down are a good indicator of a bunch of immature clowns who can't handle facts or different analysis perspectives. Including the fact that the last several days I posted at this board that we'd see 2.70's or lower for CYTX yet for a possible entry range. ha ha ha
Your context is wrong for defining RSI. What I mean is that short term is using a daily chart, which is more accurate than weekly chart. short term DAILY chart shows approx 43 on RSI. If you want to be more accurate on buying CYTX at best spot, you need to evaluate using a daily chart range. Perhaps you are a longer term investor or perhaps the weekly scale is how you prefer, but factually the daily chart is going to get you more accurate reading on what recent trading indicators are. And I emphasize you to take that into consideration because the daily chart is showing 40's yet for RSI & it will serve you best if you are looking for best spot to add to CYTX for example. If you are using a weekly RSI for basis, then there will be less difference comparing 3.00 to 2.50 for example. If you want better RSI accuracy and other indicators for oversold metrics, the daily chart will help you for deciding entry. I was the guy the last few days that posted 2.30-2.70's for a likely short term range for CYTX (when CYTX was 3+) & i used daily chart analysis & have been right so far. Only if you don;t care about more accurate lower entry or a difference of 2.50 compared to 3 for example, then go ahead and just use your weekly chart if you don;t care about a more accurate price measurement and better entry.... LOL
just double checked rsi on a 2 year chart and yesterday sat around 32 and today is sitting around 25.I consider that way oversold and due for another nice run probably to start monday morning through thursday.Idouble checked the charts and either they are skewed or i am right.
RSI on CYTX would be near 30 to be 'way oversold', so today does not qualify being at RSI 40's. But it does look like it could bounce from 2.70 range. however, I would wait yet to see if technicals confirm upside yet before declaring bounce upward (excluding any surprise new items alter next week). CYTX could still see 2.30-2.50 yet before going back up, so be prepared.
Markets starting to weaken before the weekend close.....guess they are afraid of bad news from Putin or China.
Lets see what CYTX can hold
Mar 14 2014, 13:40 ET
Senators Barbara Boxer ((D-CA)) and Mark Kirk ((R-IL)) introduce legislation that will establish a national strategy to support regenerative medicine (RM) research.
Among the requirements of the Regenerative Medicine Promotion Act are: a report by the GAO identifying all ongoing federal programs and activities pertaining to RM, the establishment of a Regenerative Medicine Coordinating Council and the maintenance of a national strategy for the promotion of RM R&D.
Companies involved in the space include (ONVO) (HART) (CUR) (CYTX) (STEM) (ATHX)
Sentiment: Strong Buy
Cytori is actively pursuing:
Chronic Heart Failure: Cytori has been advancing through clinical trials in the United States and Europe since 2007 with the aim of providing new treatment options to patients in need. Learn More
By Jennie Montgomery, WJBF Anchor
Augusta, GA -
UPDATED: 6pm News 3/12/14
You've heard of conventional treatments for heart patients, like stents. They're a Band-Aid compared to a cutting-edge research at the Medical College of Georgia at Georgia Regents University.
Stem cell therapy is an exciting breakthrough in regenerative medicine... using a patient's own stem cells to treat a weak heart muscle.
This is the kind of medicine that makes you think of medical technology meeting science fiction!
There is no approved stem cell therapy for the heart right now, but a national study going on at the medical college at Georgia Regents University could change all that.
WJBF News Channel 6's Jennie Montgomery has details.
This is a 3-dimensional map of the heart... and all roads lead to improved blood flow and heart function IF a clinical trial at GR Health System shows positive results.
"And the red zones are all zones that are scarred, and if you take this map and scrunch it up, like an accordion, you generate this map right here, and everything that's in red is densely scarred heart."
Dr. Adam Berman is the director of Cardiac Arrhythmia Ablation Services at GR Health System. He is the principal investigator of the study which is being done at several institutions across the country, taking stem cells from the patient's own bone marrow. The bone marrow is sent to an Aastrom Biosciences research laboratory where the stem cells are significantly expanded.
Berman then injects the stem cells back into multiple weak points in the heart-- using a catheter inserted through an artery at the groin, up into the heart.
"In the study we typically do about 20 injections within the healthier territories of the heart, with that needle, and that's the actual needle."
The difference between stem cell therapy- and conventional therapy, like a stent- is that the idea behind stem cells is "regenerative medicine," which is kind of like allowing the body to heal itself.
"what cytx has is patents for procedures...that is more valuable than the machines, which are similar to cotton candy machines..."
I think it's better to view the machines as the razor and disposables as the blades. The more razors out there, the more higher margin blades one can expect to sell. Good clinical and investigator results and favorable regulatory treatment (e.g., BARDA, Japan, China) will facilitate the placement of razors and the use of blades.
Looks like the buyers are getting more aggressive today which means the brief sell on the news puking may be over. This continues the recent trend of ongoing accumulation and may successfully defend the technical uptrend support. Interesting that the warrants are bid and traded higher than the Sep $2.50 call options are offered. Speculators should buy the options for 80 cents rather than paying more for the warrants.
This was close to the bottom of the uptrend line.
I guess we see how the day closes and what the general markets do today but accumulation still seems intact.
Also noticed the shares avail for shorting are getting a bit tighter.
Not making a specific call but just a observation before I step out for a few hours.
the machines are basically centrifuges...what cytx has is patents for procedures...that is more valuable than the machines, which are similar to cotton candy machines...
This is exactly where I expected CYTX to fall after the missed revenue numbers. No need to panic, the support will hold here barring any surprises or world disasters including government upheavals. It will be gradually up from here until significant news is released on the progress in a number of areas as others have posted here like the Titan. Then, depending upon the news that could come at any time, watch for significant jumps in the SP. These significant news items will be preceded by increased volumes 1-3 days before the actual news releases. Of course all of this is JMO, do your own DD before investing!
Sentiment: Strong Buy